Forecast: Chronic Liver Diseases and Cirrhosis Mortality in the US

The mortality rate for chronic liver diseases and cirrhosis in the US shows a steady increase from 2024 to 2028. Key values start at 24.0 units per hundred thousand men in 2024, rising to 27.4 units by 2028. The year-on-year growth rates are consistent, hovering around 3-4% annually. Specifically, the year-on-year percentage change from 2024 to 2025 is approximately 3.75%, from 2025 to 2026 is around 3.61%, from 2026 to 2027 is about 3.10%, and from 2027 to 2028 is close to 3.01%. The compound annual growth rate (CAGR) over the five-year forecast period is approximately 3.37%.

This upward trend suggests that chronic liver disease and cirrhosis pose an increasing health concern for the male US population. Future factors to watch include advancements in medical treatments, public health initiatives targeting alcohol consumption and hepatitis prevention, as well as changes in socioeconomic conditions that affect health outcomes.